Social/Ethical/Access/Regulatory Issues

P16.01
HIV Vaccine Acceptability and Behavioural Risk Compensation Among Men Who Have Sex with Men in a Resource-Poor Setting in Africa

OA Busari, N Martha, A Busari, SM Agboola

P16.02
HIV and STI Prevalence Among Men Who Have Sex with Men Recruited Through Respondent Driven Sample in a Nigerian Oil-Rich Port Harcourt City, Nigeria

OA Busaro, M Nakayima, A Adeyemi, S Agboola

P16.03
Are Adults in Soweto Still Willing to Participate in Future Vaccine Trials? A Qualitative Study

J Dietrich, P Maesela, A Kagee, G Gray

P16.04
Preparing for the Availability of a Partially Effective HIV Vaccine

RT Chen, C Hankins, S Osmanov, J Esparza, NL Michael, M McCluskey, M Warren

P16.05
HIV Vaccine Knowledge, Concerns and Misconceptions Among Vulnerable Communities in Resource-Poor Settings of Two Adjoining Border Cities in Africa

OA Busari, S Agboola, A Busari, M Nakayima, A Adeyemi

P16.06
Sustaining Community Interest on the Road Towards an HIV Vaccine

S Sigirenda, W Kidega, L Nielsen 

P16.07
Community Engagement in HIV Vaccine Research: A Multiple Embedded Case Study in Canada, India, South Africa and Thailand

PA Newman, G Lindegger, V Chakrapani, S Roungprakhon, C Slack, Z Essack, J Koen, M Shanmugam, S Tepjan, C Logie

P16.08
Sustaining Scientific Momentum in an Uncertain Global Economic Environment: The HIV Vaccine Funding Landscape in 2010

KA Fisher, C Avila, B Gobet, T Harmon, P Harrison, R Lande, W Lee, W Muchenje, M Warren

P16.09
A Social Vaccine? Social and Structural Correlates of HIV Vaccine Acceptability Among Key Populations at Higher Risk of HIV Exposure in Thailand

PA Newman, S Roungprakhon, S Tepjan, S Yim

P16.10
Community Conversations Around Good Participatory Practice Guidelines: The Need for Dialogue Between Communities, Governments and Researchers

G Calazans, J Beloqui